Clinical trial
Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease
NCT06345638 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sex Hormones and Inflammatory Biomarkers in Patients With Sickle Cell Disease
- Lead sponsor
- University of Pennsylvania
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2024
- Completion date
- June 17, 2025
- Enrollment
- 52 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease, vaso-occlusive crisis